Repeated-dose toxicity and immunogenicity evaluation of norovirus P particle-based rotavirus vaccine in juvenile cynomolgus monkeys - Summary - MDSpire

Repeated-dose toxicity and immunogenicity evaluation of norovirus P particle-based rotavirus vaccine in juvenile cynomolgus monkeys

  • By

  • Wei Pan

  • Yingjie Cheng

  • Xiaojing Shi

  • Yunxiang Chen

  • Cong Xu

  • Zhengbiao Yang

  • Qijiong Lu

  • Lei Wen

  • Fang Liu

  • Tingli Bian

  • Li Qin

  • Shuizhen Pan

  • Ying Chen

  • Changwei Wu

  • Lijiang Zhang

  • Hongzhong Yang

  • June 9, 2026

  • 0 min

Share

Objective:

To evaluate the repeated-dose toxicity and immunogenicity of a bivalent rotavirus subunit candidate vaccine PP-P[6]/P[8]-VP8 Mix (containing equal amounts of P[6]-VP8 and P[8]-VP8 chimeric antigens) in cynomolgus monkeys.

Key Findings:
  • No toxicologically significant abnormalities were observed during the study, indicating a favorable safety profile for the vaccine.
  • Histopathological examination revealed mild subacute inflammatory reactions at the injection site and lymphoid follicle hyperplasia in draining lymph nodes.
  • These findings are typical local immune response manifestations associated with aluminum adjuvant vaccines.
Interpretation:

The study demonstrates the safety and immunogenicity of the PP-P[6]/P[8]-VP8 Mix vaccine under experimental conditions.

Limitations:
  • The study was conducted in a controlled environment with a limited sample size (5 monkeys per group).
  • Long-term effects and efficacy in humans remain to be evaluated.
Conclusion:

The findings support the entry of the PP-P[6]/P[8]-VP8 Mix vaccine into clinical research.

Original Source(s)

Related Content